Sol-Gel Technologies Ltd To Host Virtual KOL Event On Gorlin Syndrome And The Upcoming Phase 3 Trial For SGT-610
Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease burden, SGT-610 and the upcoming Phase 3 trial NESS ZIONA, Israel,
